Molecular Diagnostics Market Size Predicted to Hit USD 23.9 billion by 2030 at 9.86% CAGR, Says AMR

𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞 𝐢𝐧 𝐭𝐡𝐞 𝐩𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐮𝐬 𝐝𝐢𝐬𝐞𝐚𝐬𝐞𝐬 𝐚𝐧𝐝 𝐯𝐚𝐫𝐢𝐨𝐮𝐬 𝐭𝐲𝐩𝐞𝐬 𝐨𝐟 𝐜𝐚𝐧𝐜𝐞𝐫 𝐝𝐫𝐢𝐯𝐞𝐬 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐎𝐧 𝐭𝐡𝐞 𝐨𝐭𝐡𝐞𝐫 𝐡𝐚𝐧𝐝, 𝐬𝐭𝐫𝐢𝐧𝐠𝐞𝐧𝐭 𝐫𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲 𝐫𝐞𝐪𝐮𝐢𝐫𝐞𝐦𝐞𝐧𝐭𝐬 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐨𝐟 𝐧𝐞𝐰 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐭𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞𝐬 𝐚𝐫𝐞 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐡𝐢𝐧𝐝𝐞𝐫 𝐭𝐡𝐞 𝐠𝐫𝐨𝐰𝐭𝐡 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭. 𝐇𝐨𝐰𝐞𝐯𝐞𝐫, 𝐬𝐮𝐫𝐠𝐞 𝐢𝐧 𝐚𝐝𝐨𝐩𝐭𝐢𝐨𝐧 𝐨𝐟 𝐭𝐡𝐞 𝐦𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐞𝐦𝐞𝐫𝐠𝐢𝐧𝐠 𝐞𝐜𝐨𝐧𝐨𝐦𝐢𝐞𝐬 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐨𝐟𝐟𝐞𝐫 𝐧𝐮𝐦𝐞𝐫𝐨𝐮𝐬 𝐨𝐩𝐩𝐨𝐫𝐭𝐮𝐧𝐢𝐭𝐢𝐞𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲.

Allied Market Research published a report, titled, “Molecular Diagnostics Market by Type (Instruments, Reagents, Software & Services), by Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Others), by Application (Infectious diseases, Oncology, Genetic testing, Blood screening, Others), by End User (Hospital, Reference Labortories, Others): Global Opportunity Analysis and Industry Forecast, 2020-2030. ” According to the report, the global molecular diagnostics industry was estimated at $9.2 billion in 2020, and is anticipated to hit $23.9 billion by 2030, registering a CAGR of 9.86% from 2021 to 2030.

The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐆𝐫𝐚𝐩𝐡𝐬 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬 𝐇𝐞𝐫𝐞: https://www.alliedmarketresearch.com/request-sample/2170

𝐓𝐨𝐩 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬

• Abbott Laboratories
• Becton
• Hoffmann-La Roche AG
• Qiagen N.V.
• Hologic Corporation
• Grifols
• Danaher Corporation, S.A.
• Agilent Inc.
• Dickinson and Company
• BioMérieux SA
• Siemens Healthcare GmbH

𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧

Based on product type, the reagents segment accounted for more than half of the global molecular diagnostics market share in 2020, and is anticipated to rule the roost by 2030. The same segment would also cite the fastest CAGR of 10.16% throughout the forecast period. Advancement in R&D activities in pharmaceutical & biotechnology industry, increase in demand for reagents, and surge in adoption of point-of-care testing drive the segment growth.

Based on application, the infectious diseases segment held nearly half of the global molecular diagnostics market revenue in 2020, and is expected to lead the trail by 2030, due to the growing incidence of infectious diseases such as SARS-COV-19. The genetic testing segment, on the other hand, would manifest the fastest CAGR of 10.31% from 2021 to 2030. This is attributed to the increase in the prevalence of genetic diseases among individuals across the world.

Based on region, North America, held the major share in 2020, generating more than two-fifths of the global molecular diagnostics market, due to the presence of large number of key players across the region. At the same time, the market across Asia-Pacific would grow at the fastest CAGR of 10.78% by 2030, owing to higher adoption & increased use of molecular diagnostics, rapidly growing geriatric population, and rise in the incidence of infectious diseases across the province.

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.alliedmarketresearch.com/purchase-enquiry/2170

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the molecular diagnostics market analysis from 2020 to 2030 to identify the prevailing molecular diagnostics market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the molecular diagnostics market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global molecular diagnostics market trends, key players, market segments, application areas, and market growth strategies.

𝐎𝐮𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧 𝐏𝐫𝐨𝐯𝐢𝐝𝐞𝐬 𝐘𝐨𝐮 𝐀𝐧𝐬𝐰𝐞𝐫 𝐭𝐨 𝐁𝐞𝐥𝐨𝐰 𝐌𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

Region Analysis

• North America

(U.S., Canada, Mexico)

• Europe

(Germany, France, UK, Italy, Spain, Rest of Europe)

• Asia-Pacific

(Japan, China, India, Rest of Asia-Pacific)

• LAMEA

(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐃𝐞𝐭𝐚𝐢𝐥𝐬:

David Correa

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022

[email protected]

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.